Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

SHA:603079 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	244.56	315.62	323.72	320.72	514.75	461.31
Short-Term Investments	30	30	-	10	20.07	110.11
Trading Asset Securities	1.01	0.01	3.01	-	0.01	-
Cash & Short-Term Investments	275.57	345.63	326.74	330.72	534.83	571.42
Cash Growth	-3.25%	5.78%	-1.20%	-38.16%	-6.40%	40.20%
Accounts Receivable	160.37	141.24	119.26	135.9	133.38	115.02
Other Receivables	0.67	0.55	0.6	0.85	0.17	0.4
Receivables	161.04	141.79	119.86	136.75	133.55	115.42
Inventory	205.07	197.54	228.48	292.06	222.09	167.94
Other Current Assets	21.71	23.81	20.07	20.83	28.35	26.36
Total Current Assets	663.38	708.77	695.15	780.36	918.81	881.15
Property, Plant & Equipment	820.56	769.47	674.77	561.81	579.96	576.02
Long-Term Investments	10.7	21.01	60.7	60.7	20.74	10.7
Goodwill	10.91	10.91	10.91	10.91	10.91	10.91
Other Intangible Assets	227.64	225.58	231.82	218.2	156.09	165.59
Long-Term Deferred Tax Assets	0.37	0.06	0.89	5.36	3.38	2.89
Long-Term Deferred Charges	5.39	6.16	8.67	4.23	6.87	11.18
Other Long-Term Assets	67.51	43.35	36.28	13.64	68.06	42.44
Total Assets	1,806	1,785	1,719	1,655	1,765	1,701
Accounts Payable	162.02	155.44	129.61	164	151.33	106.78
Accrued Expenses	12.82	38.31	33.84	37.57	36.03	36.14
Short-Term Debt	30.03	30.82	94.75	41.76	167.39	121.23
Current Portion of Long-Term Debt	0.46	0.11	0.14	-	-	-
Current Portion of Leases	-	0.8	0.3	0.59	0.59	-
Current Income Taxes Payable	13.51	3.38	2.98	5.04	3.21	20.02
Current Unearned Revenue	3.39	3.8	2.92	8.7	6.54	4.04
Other Current Liabilities	2.12	18.71	30.9	37.81	47.4	70.56
Total Current Liabilities	224.35	251.38	295.45	295.46	412.5	358.76
Long-Term Debt	256	231	144	-	-	-
Long-Term Leases	0.49	0.49	-	0.3	0.87	-
Long-Term Unearned Revenue	6.56	6.65	5.46	7.58	6.95	4.69
Long-Term Deferred Tax Liabilities	3.58	3.71	4.28	8.43	7.53	6.44
Other Long-Term Liabilities	8.1	8.1	-	-	-	5.92
Total Liabilities	499.08	501.34	449.2	311.78	427.84	375.8
Common Stock	171.19	171.19	171.19	171.19	171.19	171.19
Additional Paid-In Capital	669.19	669.19	669.19	669.19	669.19	669.19
Retained Earnings	464.24	442.53	423.26	487.6	480.09	464.25
Treasury Stock	-22.08	-22.08	-8.97	-	-	-
Total Common Equity	1,283	1,261	1,255	1,328	1,320	1,305
Minority Interest	24.85	23.14	15.31	15.45	16.49	20.43
Shareholders' Equity	1,307	1,284	1,270	1,343	1,337	1,325
Total Liabilities & Equity	1,806	1,785	1,719	1,655	1,765	1,701
Total Debt	286.98	263.23	239.2	42.65	168.85	121.23
Net Cash (Debt)	-11.41	82.4	87.54	288.07	365.98	450.19
Net Cash Growth	-	-5.86%	-69.61%	-21.29%	-18.70%	777.43%
Net Cash Per Share	-0.07	0.48	0.52	1.65	2.13	2.67
Filing Date Shares Outstanding	169.32	169.32	169.32	171.19	171.19	171.19
Total Common Shares Outstanding	169.32	169.32	170.46	171.19	171.19	171.19
Working Capital	439.03	457.38	399.69	484.9	506.32	522.39
Book Value Per Share	7.57	7.45	7.36	7.76	7.71	7.62
Tangible Book Value	1,044	1,024	1,012	1,099	1,153	1,128
Tangible Book Value Per Share	6.17	6.05	5.94	6.42	6.74	6.59
Buildings	-	290.21	279.73	274.11	272.42	271.23
Machinery	-	589.14	528.41	515.04	479.2	449.64
Construction In Progress	-	335.96	247.32	93.33	88.76	61.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.